Screener
Hemab Therapeutics Holdings, Inc. COAG Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $237,366 | $87,974 |
| Marketable securities | 220,094 | 97,511 |
| Prepaid expenses and other current assets | 6,538 | 7,066 |
| Total current assets | 463,998 | 192,551 |
| Property and equipment, net | 596 | 609 |
| Operating right-of-use assets | 901 | 1,092 |
| Other non-current assets | 2,286 | 531 |
| Total assets | $467,781 | $194,783 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s total current assets?
- Hemab Therapeutics Holdings, Inc. (COAG) reported total current assets of $464M in Q2 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude